Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/14/25 16:31 | 10/9/25 | VSTM | Health | Drug | Pharmaceutical Preparations | Bunn Paul A. | MA | D | 1 | S | -75 | 9.06 | 0 | -8 | 8 | D | ||||||||||||||||
9/24/25 16:30 | 9/22/25 | VSTM | Health | Drug | Pharmaceutical Preparations | Calkins Daniel | MA | O | CFO | 11 | S.m | -114 | 7.25 | 0 | -16 | 114 | D | |||||||||||||||
9/18/25 18:16 | 9/16/25 | VSTM | Health | Drug | Pharmaceutical Preparations | Stuglik Brian M | MA | D | 7 | S.dm | -23 | 5.09 | 0 | -5 | 102 | D | ||||||||||||||||
9/18/25 18:14 | 9/16/25 | VSTM | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | 7 | S.dm | -11 | 5.16 | 0 | -2 | 42 | D | ||||||||||||||||
9/18/25 18:11 | 9/16/25 | VSTM | Health | Drug | Pharmaceutical Preparations | Paterson Dan | MA | DO | P,CEO | 15 | S.m | -654 | 6.93 | 0 | -94 | 462 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |